Autolus Therapeutics plc (AUTL) is gaining attention with FDA approval for its CAR-T therapy Aucatzyl. Despite financial challenges, strong clinical data and cash reserves position the company well for growth.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing